Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversiti Putra Malaysia

About this trial

The goal of this InTroDuce-Programme interventional trial aims to test whether a web-based educational program can improve pregnant women's knowledge about Influenza and Tdap vaccinations and increase their intention to get vaccinated in the future. The main questions it aims to answer are:

Does the InTroDuce-Programme increase knowledge and future intention of pregnant mothers to get vaccinated against Influenza and Tdap? How does demographic factors, attitudes and barriers affect vaccination decisions among pregnant mothers?

Researchers will compare InTroDuce-Programme to standard care (routine antenatal care) to see if InTroDuce-Programme works to improve knowledge and future intention of pregnant mothers to be vaccinated against Influenza and Tdap. Participants will:

Receive the web-based educational module (InTroDuce-Programme), which covers the importance, safety, and effectiveness of vaccinations, as well as addressing common concerns.

Be followed up one month after the intervention. Answer questionnaires before and after the intervention to measure changes in vaccination knowledge and future intention to get vaccinated

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Pregnant women aged 18 years and older

Before or equal to 32 weeks of gestation as we need to follow-up the patients again at 36 weeks of gestation before delivery occurs.

Able to understand and consent to participation in the study.

Disqualifiers

Pregnant women with severe anaphylactic or allergic reactions to previous dose of influenza or Tdap vaccination.

Non-Malaysian

Trial design

Design model

Parallel

Treatments tested in this trial

  • Influenza and Tdap Vaccination Educational and Learning Module

    Behavioral

    Influenza and Tdap learning and educational module delivered via website. The module will cover importance of vaccination for both pregnant women and infant, safety and efficacy of the influenza and TdaP vaccines, timing of vaccination, and addressing common concerns and misconceptions.

Treatment groups

351 Participants
are divided into 2 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: InterventionExperimental treatment 0 interventions

Trial outcomes

Primary outcomes

1

Knowledge of Influenza and Tdap Vaccination

knowledge score about the importance, safety, and benefits of vaccination (vaccine literacy) will be assessed through pre- and post-intervention questionnaire

Time frame
1 month post-intervention
2

Vaccination Future Uptake

Intention of future vaccine uptake of the influenza and Tdap vaccines will be assessed using questionnaire

Time frame
1 month post-intervention

Secondary outcomes

1

Barriers to vaccination uptake

Identification of barriers to vaccination uptake and socio-demographic factors influencing outcomes.

Time frame
1 month post-intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.